Abstract: A technique capable of certainly suppressing adhesion of waste ink to hands, clothes, and the like during replacement of a waste ink tank is provided. There are included a container portion provided with an insertion port which a discharge member discharging waste ink can be inserted into and pulled out from and a shielding portion movable between a shielding position where the insertion port is shielded and an open position where the insertion port is opened.

Abstract: A backlight for providing illumination to a liquid crystal panel includes a reflective polarizer and an extended light source. The extended light source includes a diffuse reflective film assembly and an emission surface disposed between the reflective polarizer and the diffuse reflective film assembly. The extended light source is configured to emit light through the emission surface toward the reflective polarizer. The diffuse reflective film assembly includes a specularly reflective film and an optically diffusive film disposed between the emission surface and the specularly reflective film. The optically diffusive film is bonded to the specularly reflective film at a plurality of discrete spaced apart bonded locations with a total bonding area of less than about 20%.

Abstract: In an exhaust gas purification catalyst, a catalytic component (100) containing a first oxide (21), a second oxide (22), and a precious metal (30) is supported on a three-dimensional structure (10); the ratio of the amount of precious metal (30) supported on the first oxide (21) to the total amount of precious metal (30) supported on the first oxide (21) and precious metal (30) supported on the second oxide (22), or the ratio of the amount of precious metal (30) supported on the second oxide (22) to the total amount of precious metal (30) supported on the first oxide (21) and precious metal (30) supported on the second oxide (22) is 70% or more to 100% or less, as measured by an electron probe microanalyzer (EPMA); and the amount of carbon monoxide that the precious metal (30) can adsorb per unit mass is 15 mL/g or more to 100 mL/g or less.

Abstract: A backlight for providing illumination to a liquid crystal panel includes a reflective polarizer and an extended light source. The extended light source includes a diffuse reflective film assembly and an emission surface disposed between the reflective polarizer and the diffuse reflective film assembly. The extended light source is configured to emit light through the emission surface toward the reflective polarizer. The diffuse reflective film assembly includes a specularly reflective film and an optically diffusive film disposed between the emission surface and the specularly reflective film. The optically diffusive film is bonded to the specularly reflective film at a plurality of discrete spaced apart bonded locations with a total bonding area of less than about 20%.

Abstract: Cystic fibrosis is developed through mutation of Cystic Fibrosis Transmembrane conductance Regulator (CFTR), which is one type of chloride channel. An object of the present invention is to provide compounds effective in the treatment of cystic fibrosis that open a chloride channel different from CFTR, which is the cause of the disease, and do not depend on CFTR. Compounds of the present invention are compounds or pharmaceutically acceptable salts thereof that open calcium dependent chloride channels (CaCCs) via G-protein coupled receptor 39 (GPR39) agonism to have strong chloride ion-secretory action, and are represented by the following general formula (I): General formula (I): wherein, X represents a carboxyl group or a tetrazolyl group; Q represents a C1-C3 alkylene group, an oxygen atom, a sulfur atom, etc.; G represents a phenyl group where the phenyl group may have 1 to 3 substituents independently selected from the group consisting of a halogen atom, a cyano group, a C1-C6 alkyl group, etc.

Abstract: Cystic fibrosis is developed through mutation of Cystic Fibrosis Transmembrane conductance Regulator (CFTR), which is one type of chloride channel. An object of the present invention is to provide compounds effective in the treatment of cystic fibrosis that open a chloride channel different from CFTR, which is the cause of the disease, and do not depend on CFTR. Compounds of the present invention are compounds or pharmaceutically acceptable salts thereof that open calcium dependent chloride channels (CaCCs) via G-protein coupled receptor 39 (GPR39) agonism to have strong chloride ion-secretory action, and are represented by the following general formula (I): General formula (I): wherein, X represents a carboxyl group or a tetrazolyl group; Q represents a C1-C3 alkylene group, an oxygen atom, a sulfur atom, etc.; G represents a phenyl group where the phenyl group may have 1 to 3 substituents independently selected from the group consisting of a halogen atom, a cyano group, a C1-C6 alkyl group, etc.

Abstract: The present invention is intended to provide a compound or a pharmacologically acceptable salt thereof which is useful in the treatment of a tumor through its ROS1 kinase enzyme activity inhibitory effect and NTRK kinase enzyme inhibitory effect. The present invention provides a compound having an imidazo[1,2-b]pyridazine structure represented by the general formula (I) or a pharmacologically acceptable salt thereof, and a pharmaceutical composition comprising the compound. In the formula, R1, G, T, Y1, Y2, Y3, and Y4 are as defined herein.

Abstract: The present invention is intended to provide a compound or a pharmacologically acceptable salt thereof which is useful in the treatment of a tumor through its ROS1 kinase enzyme activity inhibitory effect and NTRK kinase enzyme inhibitory effect. The present invention provides a compound having an imidazo[1,2-b]pyridazine structure represented by the general formula (I) or a pharmacologically acceptable salt thereof, and a pharmaceutical composition comprising the compound. In the formula, R1, G, T, Y1, Y2, Y3, and Y4 are as defined herein.

Abstract: The present invention is intended to provide a compound or a pharmacologically acceptable salt thereof which is useful in the treatment of a tumor through its ROS1 kinase enzyme activity inhibitory effect and NTRK kinase enzyme inhibitory effect. The present invention provides a compound having an imidazo[1,2-b]pyridazine structure represented by the general formula (I) or a pharmacologically acceptable salt thereof, and a pharmaceutical composition comprising the compound. In the formula, R1, G, T, Y1, Y2, Y3, and Y4 are as defined herein.

Abstract: The present invention is intended to provide a compound or a pharmacologically acceptable salt thereof which is useful in the treatment of a tumor through its ROS1 kinase enzyme activity inhibitory effect and NTRK kinase enzyme inhibitory effect. The present invention provides a compound having an imidazo[1,2-b]pyridazine structure represented by the general formula (I) or a pharmacologically acceptable salt thereof, and a pharmaceutical composition comprising the compound. In the formula, R1, G, T, Y1, Y2, Y3, and Y4 are as defined herein.

Abstract: The present invention provides a method for effectively producing an optically active form of tetrasubstituted-5-azaspiro[2.4]heptane derivative, which serves as a useful production intermediate for quinolonecarboxylic acid antibacterial agents, and intermediates for the derivative. The present invention is directed to a method for producing a compound (VII) according to the following scheme.

Abstract: Disclosed is an epoxy resin composition which is solid at ordinary room temperature, cures with excellent light resistance and heat resistance and minimal shrinkage, and is useful for encapsulating LEDs. The epoxy resin composition is characterized by comprising as an essential component an epoxy resin having an epoxy equivalent of 300-1000 g/eq and a softening point of 65-110° C. obtained by reacting a nonaromatic polycarboxylic acid (A) having an acid value of 100-250 mgKOH/g with a nonaromatic epoxy resin (B) having an epoxy equivalent of 100-400 g/eq. The nonaromatic polycarboxylic acid (A) may be obtained by reacting 1,4-cyclohexanedimethanol, 2,2-bis(4-hydroxycyclohexyl)propane, or 3,9-bis(1,1-dimethyl-2-hydroxyethyl)-2,4,8,10-tetraoxaspiro[5,5]undecane with methylhexahydrophthalic acid or hexahydrophthalic acid.

Abstract: The present invention provides a method for effectively producing an optically active form of tetrasubstituted-5-azaspiro[2.4]heptane derivative, which serves as a useful production intermediate for quinolonecarboxylic acid antibacterial agents, and intermediates for the derivative. The present invention is directed to a method for producing a compound (VII) according to the following scheme.

Abstract: Disclosed is an epoxy resin composition which is solid at ordinary room temperature, cures with excellent light resistance and heat resistance and minimal shrinkage, and is useful for encapsulating LEDs. The epoxy resin composition is characterized by comprising as an essential component an epoxy resin having an epoxy equivalent of 300-1000 g/eq and a softening point of 65-110° C. obtained by reacting a nonaromatic polycarboxylic acid (A) having an acid value of 100-250 mgKOH/g with a nonaromatic epoxy resin (B) having an epoxy equivalent of 100-400 g/eq. The nonaromatic polycarboxylic acid (A) may be obtained by reacting 1,4-cyclohexanedimethanol, 2,2-bis(4-hydroxycyclohexyl)propane, or 3,9-bis(1,1-dimethyl-2-hydroxyethyl)-2,4,8,10-tetraoxaspiro[5,5]undecane with methylhexahydrophthalic acid or hexahydrophthalic acid.

Abstract: A compound represented by the general formula (1) [X1 and X2 represent hydrogen atom, a halogen atom, hydroxyl group and the like, R1 represents a phenyl group, R2 represents an alkyl group, an alkenyl group, or an alkoxy group, R3 represents hydrogen atom, a halogen atom, hydroxyl group, or an alkoxy group, R4 represents hydrogen atom, or an alkyl group, Z1 and Z2 represent hydrogen atom, a halogen atom, hydroxyl group and the like, Z3 represents cyano group, an alkyl group, an alkenyl group and the like, Z4 represents an alkyl group, an alkenyl group, an alkynyl group and the like, and represents a single bond or a double bond], which shows high antitumor effect against cancer cells including drug resistant cells.

Abstract: This invention relates to an epoxy resin composition suitable for a solvent-free, one-component, room temperature-curable coating composition and to an epoxy-polysiloxane coating composition showing good adhesion to steel plates and the like and excellent weatherability. This epoxy resin composition comprises (a) an epoxy resin with an epoxy equivalent of 100-1000 g/eq., (b) a silane compound represented by the following general formula (1) Si(R1R2R3R4)??(1) (wherein R1 is an alkyl group of 1-6 carbon atoms and R2-R4 are hydrogen atoms, alkyl groups of 1-10 carbon atoms, aryl groups, hydroxyl groups, or alkoxy groups of 1-6 carbon atoms) and a condensate thereof, and (c) a phosphoric acid represented by the following general formula (2) H(n+2)PnO(3n+1)??(2) as essential components.

Abstract: To provide an image-recording medium, which can form a high quality image thereon without yellowing (the shift of color tone) or the blotting of the ink with both the dye ink and the pigment ink. An image-recording medium having a support having breathing micropores, the surfaces and the micropores of which are made hydrophilic, and an ink-receptive layer which is provided on the surface of the support and comprises a binder and a coagulant, characterized in that the ink-receptive layer contains a cationic organic oligomer having a cationic functional group in the molecule, or a cationic polymer having a cationic functional group in the molecule as a coagulant.

Abstract: A vicinity search using register point data in a designated area reduces search time. The vicinity search data include at least category information, names of register points and country information. The search device conducts the vicinity search by specifying any one of category information to which the register points belong, names of the register points and country information, or a combination, by option and display. The search device further uses category information with flags representing the presence and absence of the register point data, whereby the register point data are searched by referring to the flags.

Abstract: To provide an image-recording medium, which has increased adhesion between an image-receptive layer and a retroreflective sheet, can easily increase the outdoor durability including water resistance, and can effectively increase the retroreflection luminance of an image-recorded surface.

Abstract: This invention is to provide a novel taxol derivative useful as an antitumor compound having respective substituent groups, represented by the following formula (I) which can be orally administered